These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1473041)

  • 1. Increased microalbuminuria in diabetic rats is independent of angiotensin II or glomerular proteoglycan synthesis.
    Whiteside C; Templeton DM
    Can J Physiol Pharmacol; 1992 Aug; 70(8):1096-103. PubMed ID: 1473041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats.
    Jyothirmayi GN; Reddi AS
    Hypertension; 1993 Jun; 21(6 Pt 1):795-802. PubMed ID: 8500860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
    Klein DJ; Oegema TR; Brown DM
    Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
    Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
    Templeton DM
    Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
    Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
    Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of galactose regimen on glomerular heparan sulfate synthesis and albumin excretion in diabetic rats.
    Jaya B; Hu L; Bauman JW; Fu SC; Reddi AS
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):143-52. PubMed ID: 8321919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
    Whiteside CI; Thompson J
    Endocrinology; 1989 Oct; 125(4):1932-40. PubMed ID: 2551633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes.
    Moriya T; Nakazawa K; Itoh N; Shigematsu H; Okada N; Aizawa T; Yamada T; Yajima Y
    Nephron; 1993; 65(3):444-8. PubMed ID: 8289997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes.
    Cohen MP; Surma ML
    J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of albuminuria by captopril in diabetic rats.
    Reddi AS
    Gen Pharmacol; 1991; 22(2):323-8. PubMed ID: 2055428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence.
    Kanwar YS; Rosenzweig LJ; Linker A; Jakubowski ML
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2272-5. PubMed ID: 6572976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in glomerular proteoglycan metabolism in experimental non-insulin dependent diabetes mellitus.
    Fioretto P; Keane WF; Kasiske BL; O'Donnell MP; Klein DJ
    J Am Soc Nephrol; 1993 Apr; 3(10):1694-704. PubMed ID: 8318686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism.
    Wilkes BM
    Endocrinology; 1987 Apr; 120(4):1291-8. PubMed ID: 3549258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
    Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
    Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
    Singh R; Singh AK; Leehey DJ
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1183-90. PubMed ID: 15701818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate analysis from diabetic rat glomeruli.
    Lauer ME; Hascall VC; Wang A
    J Biol Chem; 2007 Jan; 282(2):843-52. PubMed ID: 17038308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
    Schambelan M; Blake S; Sraer J; Bens M; Nivez MP; Wahbe F
    J Clin Invest; 1985 Feb; 75(2):404-12. PubMed ID: 3156147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.
    van den Born J; Pisa B; Bakker MA; Celie JW; Straatman C; Thomas S; Viberti GC; Kjellen L; Berden JH
    J Biol Chem; 2006 Oct; 281(40):29606-13. PubMed ID: 16885165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.